Cyclosporine-Related Posterior Reversible Encephalopathy Syndrome After Heart Transplantation: Should We Withdraw or Reduce Cyclosporine?: Case Reports

Transplantation Proceedings

Volumn 41, Issue 2, 2009, Pages 716-720

  Dzudie, A ^a   Boissonnat, P ^a   Roussoulieres, A ^a   Cakmak, ^a   Mosbah, K ^b   Bejui, F T ^a   Obadia, J F ^a   Sebbag, L ^a  

^a Louis Pradel's Cardiovascular Hospital   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; BASILIXIMAB; CLOBAZAM; COTRIMOXAZOLE; CYCLOSPORIN A; EVEROLIMUS; GABAPENTIN; MYCOPHENOLIC ACID; PREDNISONE; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; CEREBELLUM; CONVALESCENCE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; GRAFT REJECTION; GRAND MAL SEIZURE; HEADACHE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PERIPHERAL EDEMA; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; TRICUSPID VALVE ATRESIA; VISUAL DISORDER;

AGED; BRAIN; CARDIOMYOPATHY, DILATED; CEREBELLUM; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63149118724     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.041     Document Type: Article

References (17)

1. Chow K.M., and Szeto C.C. Posterior leukoencephalopathy with cyclosporine. Clin Nephrol 60 (2003) 297
2. Munoz R., Espinoza M., Espinoza O., et al. Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases. Transplant Proc 38 (2006) 921
3. Arnoldus E.P., and Van Laar T. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 (1996) 1745
4. Gijtenbeek J.M., van den Bent M.J., and Vecht C.J. Cyclosporine neurotoxicity: a review. J Neurol 246 (1999) 339
5. Tsagalou E.P., Nastasiou-Nana M.I., Margari Z.J., et al. Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation. J Heart Lung Transplant 26 (2007) 661
6. Singh N., Bonham A., and Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69 (2000) 467
7. Bechstein W.O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13 (2000) 313
8. Wijdicks E.F., Wiesner R.H., and Krom R.A. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 45 (1995) 1962
9. Serkova N.J., Christians U., and Benet L.Z. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 4 (2004) 97
10. Chang S.H., Lim C.S., Low T.S., et al. Cyclosporine-associated encephalopathy: a case report and literature review. Transplant Proc 33 (2001) 3700
11. Palmer B.F., and Toto R.D. Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis 18 (1991) 116
12. Minn A.Y., Fisher P.G., Barnes P.D., et al. A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. Pediatr Blood Cancer 48 (2007) 213
13. Kunzendorf U., Brockmoller J., Jochimsen F., et al. Neurotoxicity caused by a high cyclosporine metabolite level. Transplantation 48 (1989) 531
14. Balbontin F.G., Kiberd B., Squires J., et al. Tacrolimus monitoring by simplified sparse sampling under the concentration time curve. Transplant Proc 35 (2003) 2445
15. Coley S.C., Porter D.A., Calamante F., et al. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR Am J Neuroradiol 20 (1999) 1507
16. Wong R., Beguelin G.Z., de Lima M., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 122 (2003) 128
17. Forgacs B., Merhav J., Lappin J., et al. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 37 (2005) 1912